Docetaxel Injection shortage
Docetaxel Injection is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Sep 19, 2026.
Ingenus Pharmaceuticals is permanently discontinuing its docetaxel injection 10 mg/1 mL. Other manufacturers — including Hikma, Hospira, Sanofi-Aventis, and Accord Healthcare — have not reported a shortage and still list docetaxel injection products.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Docetaxel Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Feb 20, 2026Currently in shortage2 of 2 products affected.
-
Feb 20, 2026First reported to the FDA2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Ingenus Pharmaceuticals LLC 📞 866-321-5031 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
These rows are manufacturer reports to the FDA for Docetaxel Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Docetaxel Injection? options further down this page.
Why is Docetaxel Injection in shortage?
Ingenus Pharmaceuticals has made a business decision to permanently stop making their version of Docetaxel Injection 10 mg/1 mL. This affects two specific package configurations they produced (NDC 50742-463-16 and NDC 50742-431-08). No specific reason beyond it being a business decision was shared publicly.
It's worth knowing that this report reflects only what Ingenus Pharmaceuticals filed with the FDA — it covers just their products, not every manufacturer of docetaxel out there.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Docetaxel Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Docetaxel Injection?
Docetaxel Injection is currently on the FDA shortage list. I want to walk you through what this means so you can plan your next steps calmly.
The affected strength is the 10 mg/1 mL injection, and right now there is no available source reported for it. The manufacturer that filed this report, Ingenus Pharmaceuticals, states this is a business decision to discontinue making the drug. Because this product is listed "to be discontinued," this particular supply problem may be permanent. That said, this report reflects only one manufacturer — docetaxel is made by other companies too, so the medicine itself is still on the market in various forms and strengths.
Here is what I suggest:
- Do not stop, skip, or change your treatment on your own — this medicine is part of a carefully planned regimen.
- Since your exact strength is being discontinued, talk with your prescriber or pharmacist soon. They can look into the same medicine from another maker (for example, docetaxel is also produced by Hospira, Sagent, Hikma, Sanofi-Aventis, Accord, and Avet), though it may not sit in local stock and may come in a different concentration.
- Your care team can choose the right option for your treatment plan.
Manufacturer contact numbers are listed on this page for reference; your pharmacy usually handles those calls. This is national, manufacturer-reported data and may not match your pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Docetaxel Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Docetaxel Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Docetaxel | DOCETAXEL 20 mg/mL | Injection, Solution, Concentrate · Intravenous | Hikma Pharmaceuticals USA Inc. | 00143-9204-01 |
| Docetaxel | DOCETAXEL ANHYDROUS 10 mg/mL | Injection, Solution · Intravenous | Hospira, Inc. | 00409-0016-01 |
| Docetaxel | DOCETAXEL 20 mg/mL | Injection, Solution · Intravenous | Hospira, Inc. | 00409-0365-01 |
| Docetaxel | DOCETAXEL 20 mg/mL | Injection, Solution, Concentrate · Intravenous | Sanofi-Aventis U.S. LLC | 00955-1020-01 |
| Docetaxel | DOCETAXEL 80 mg/4mL | Injection, Solution, Concentrate · Intravenous | Sanofi-Aventis U.S. LLC | 00955-1021-04 |
| Docetaxel | DOCETAXEL 160 mg/8mL | Injection, Solution, Concentrate · Intravenous | Sanofi-Aventis U.S. LLC | 00955-1022-08 |
| Docetaxel | DOCETAXEL ANHYDROUS 20 mg/mL | Injection, Solution, Concentrate · Intravenous | Accord Healthcare Inc. | 16729-0267-63 |
| Docetaxel | DOCETAXEL 20 mg/mL | Injection · Intravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0903-31 |
| Docetaxel | DOCETAXEL 80 mg/4mL | Injection · Intravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0904-31 |
| Docetaxel | DOCETAXEL 160 mg/8mL | Injection · Intravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0905-31 |
| Docetaxel | DOCETAXEL ANHYDROUS 20 mg/mL | Injection, Solution · Intravenous | Sagent Pharmaceuticals | 25021-0245-01 |
| Docetaxel | DOCETAXEL ANHYDROUS 10 mg/mL | Injection · Intravenous | Sagent Pharmaceuticals | 25021-0254-08 |
Therapeutic equivalents & pricing 23 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Docetaxel 10 mg/mL | Hospira, | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Hospira, | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Hospira, | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Hospira, | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Sagent | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Baxter | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Baxter | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Baxter | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Baxter | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Baxter | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Alembic | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Eugia | 1 vial | — | — | FDA listed |
| Docetaxel 10 mg/mL | Eugia | 1 vial | — | — | FDA listed |
| Docetaxel 10 mg/mL | Alembic | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Sandoz | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Mylan | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Mylan | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Gland | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Gland | 1 vial | — | AP | FDA listed |
| Docetaxel anhydrous 10 mg/mL | Meitheal | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Mylan | 1 vial | — | AP | FDA listed |
| Docetaxel 10 mg/mL | Ingenus | 1 vial | — | — | Discontinued |
| Docetaxel 10 mg/mL | Ingenus | 1 vial | — | — | Discontinued |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Docetaxel Injection — that fall in the same broad treatment class (antineoplastics,miscellaneous) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other oncology shortages
Docetaxel Injection shortage FAQs
Is Docetaxel Injection in shortage?
Which products are affected?
When will Docetaxel Injection be available again?
Can I still get Docetaxel somewhere?
What should I do if I take Docetaxel Injection?
Still have a question about the Docetaxel Injection shortage?
Ask a pharmacist about this shortage →View Docetaxel Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.